Sac-TMT Combined With Toripalimab for First-line Treatment of PD-L1 Positive a/mTNBC

Clinical trial NCT07244874 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07244874
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

TNBC - Triple-Negative Breast Cancer PD-L1 Positive

Start date: 2025-12-01
Primary completion: 2028-01-30
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.